(Q57758139)

English

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

1 reference

based on heuristic

inferred from title

Eduardo Díaz-Rubio

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Roberto Labianca

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Josep Tabernero Caturla

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

E Van Cutsem

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Dicato

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R Geva

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

N Arber

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Y Bang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Benson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Cervantes

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Ducreux

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R Glynne-Jones

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Grothey

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

D Haller

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

K Haustermans

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

D Kerr

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

B Nordlinger

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J Marshall

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

B D Minsky

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Y K Kang

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Lordick

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Ohtsu

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

N Pavlidis

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Roth

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

P Rougier

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

H J Schmoll

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Sobrero

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

C Van de Velde

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J Zalcberg

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

22 Suppl 5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

v1-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Supplement 5

0 references

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

The epidemiology of gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Epidemiologic trends in esophageal and gastric cancer in the United States

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Age-specific trends in incidence of noncardia gastric cancer in US adults.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Tobacco smoking and gastric cancer: review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Diet and the risk of gastric cancer: review of epidemiological evidence

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Gastric cancer epidemiology and risk factors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Perspectives in the treatment of gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Gastric carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Hospital volume and late survival after cancer surgery

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Helicobacter pylori infection and the development of gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Imaging in local staging of gastric cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Whole-body PET with FDG for the diagnosis of recurrent gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

The role of staging laparoscopy in oesophagogastric cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Laparoscopy significantly improves the perceived preoperative stage of gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-fluorouracil before and after three-dimensional conformal radiotherapy with concurrent infusional 5-fluorouracil: a multicenter study of the Trans-Tasman Radiation Oncolog

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Classification of adenocarcinoma of the oesophagogastric junction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Localized adenocarcinoma of the esophagogastric junction--is there a standard of care?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Predictive factors of lymph node metastasis in undifferentiated early gastric cancers and application of endoscopic mucosal resection.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Hospital volume and surgical mortality in the United States.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Enforcing centralization for gastric cancer in Denmark

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Prognostic indicators in node-negative advanced gastric cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Clinicopathological characteristics and predictive markers of early gastric cancer with recurrence.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Multivariate prognostic study on large gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Chemosensitivity and survival in gastric cancer patients with microsatellite instability.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

MSI phenotype and MMR alterations in familial and sporadic gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Distinct clinical features and outcomes of gastric cancers with microsatellite instability

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Gastric cancer in the elderly: an overview

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Second-line chemotherapy of advanced disseminated gastric cancer after cisplatin, infusional 5-fluorouracil, folinic acid (PLF): benefit dependent on progression-free interval after first-line therapy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR284

21 January 2018

Identifiers

10.1093/ANNONC/MDR284

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21633049%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57758139&oldid=1671790565"